Sci-Tech Seattle: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Seattle.

Press releases published on July 30, 2026

Jul. 30, 2026

Immutep Quarterly Activities Report Q4 FY26

Indeterminate GlobeNewswire

Jul. 30, 2026

ZenaTech's DaaS Oil and Gas Business Enters a Strengthened Market with Higher Oil Prices and More Than US$500 Billion in Expected Canadian Energy Investment Over the Next Decade

Indeterminate GlobeNewswire

Jul. 30, 2026

Crusoe and Aalo Atomics Form Strategic Partnership with Goal of Deploying First Nuclear-Powered AI Factory

Indeterminate GlobeNewswire

Jul. 30, 2026

Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June

Indeterminate GlobeNewswire

Jul. 30, 2026

electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Stride Announces CEO Succession

Indeterminate GlobeNewswire

Jul. 30, 2026

Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program

Indeterminate GlobeNewswire

Jul. 30, 2026

Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Jul. 30, 2026

SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 30, 2026

Leonardo DRS Announces Financial Results for Second Quarter 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Jul. 30, 2026

Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109

Indeterminate GlobeNewswire

Jul. 30, 2026

PharmAla Issues Q3 Financial Statements and AGM Update

Indeterminate GlobeNewswire

Jul. 30, 2026

InflaRx to Report Second Quarter 2026 Results on August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing

Indeterminate GlobeNewswire

Jul. 30, 2026

Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update

Indeterminate GlobeNewswire

Jul. 30, 2026

Immunocore to report second quarter 2026 financial results and host call on August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Soulloop Acquires Astrolumi.AI to Bring Astrologer-Led Daily Practice to WhatsApp

Indeterminate GlobeNewswire

Jul. 30, 2026

INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform

Indeterminate GlobeNewswire

Jul. 30, 2026

Atavistik Bio Partners with Cure HHT Clinical Trial Network to Advance Development of ATV-1601 for Hereditary Hemorrhagic Telangiectasia

Indeterminate GlobeNewswire